Nothing Special   »   [go: up one dir, main page]

EE9900566A - Helicobacter pylori FlgE pol�peptiidi sisaldavad vaktsiinikoostised - Google Patents

Helicobacter pylori FlgE pol�peptiidi sisaldavad vaktsiinikoostised

Info

Publication number
EE9900566A
EE9900566A EEP199900566A EEP9900566A EE9900566A EE 9900566 A EE9900566 A EE 9900566A EE P199900566 A EEP199900566 A EE P199900566A EE P9900566 A EEP9900566 A EE P9900566A EE 9900566 A EE9900566 A EE 9900566A
Authority
EE
Estonia
Prior art keywords
compositions containing
helicobacter pylori
vaccine compositions
containing helicobacter
flge polypeptide
Prior art date
Application number
EEP199900566A
Other languages
English (en)
Estonian (et)
Inventor
Berglindh Thomas
Mellg�rd Bj�rn
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900566A publication Critical patent/EE9900566A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56922Campylobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP199900566A 1997-06-12 1998-06-08 Helicobacter pylori FlgE pol�peptiidi sisaldavad vaktsiinikoostised EE9900566A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (sv) 1997-06-12 1997-06-12 Vaccine compositions V
PCT/SE1998/001093 WO1998056816A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE

Publications (1)

Publication Number Publication Date
EE9900566A true EE9900566A (xx) 2000-06-15

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900566A EE9900566A (xx) 1997-06-12 1998-06-08 Helicobacter pylori FlgE pol�peptiidi sisaldavad vaktsiinikoostised

Country Status (21)

Country Link
EP (1) EP1009764A1 (xx)
JP (1) JP2002507118A (xx)
KR (1) KR20010013699A (xx)
CN (1) CN1259960A (xx)
AR (1) AR012896A1 (xx)
AU (1) AU8048798A (xx)
BR (1) BR9810026A (xx)
CA (1) CA2293293A1 (xx)
EE (1) EE9900566A (xx)
HU (1) HUP0003164A3 (xx)
ID (1) ID23052A (xx)
IL (1) IL133144A0 (xx)
IS (1) IS5288A (xx)
NO (1) NO996132L (xx)
NZ (1) NZ501427A (xx)
PL (1) PL337503A1 (xx)
SE (1) SE9702242D0 (xx)
SK (1) SK173099A3 (xx)
TR (1) TR199903060T2 (xx)
WO (1) WO1998056816A1 (xx)
ZA (1) ZA984696B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (zh) * 2015-04-27 2015-07-22 苏州大学附属第一医院 重组绿脓杆菌鞭毛钩蛋白FlgE的用途
CN113425717B (zh) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用
CN116535472B (zh) * 2023-05-31 2024-04-30 四川大学华西医院 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用
CN118105473B (zh) * 2024-04-30 2024-08-16 成都欧林生物科技股份有限公司 一种预防或治疗Hp感染口服免疫原性组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la

Also Published As

Publication number Publication date
CN1259960A (zh) 2000-07-12
JP2002507118A (ja) 2002-03-05
SE9702242D0 (sv) 1997-06-12
AU8048798A (en) 1998-12-30
IL133144A0 (en) 2001-03-19
ID23052A (id) 2000-01-20
SK173099A3 (en) 2000-06-12
WO1998056816A1 (en) 1998-12-17
IS5288A (is) 1999-12-08
HUP0003164A2 (hu) 2000-12-28
TR199903060T2 (xx) 2000-09-21
NZ501427A (en) 2000-09-29
NO996132L (no) 2000-01-28
EP1009764A1 (en) 2000-06-21
BR9810026A (pt) 2000-09-19
AR012896A1 (es) 2000-11-22
KR20010013699A (ko) 2001-02-26
ZA984696B (en) 1999-01-04
CA2293293A1 (en) 1998-12-17
PL337503A1 (en) 2000-08-28
NO996132D0 (no) 1999-12-10
HUP0003164A3 (en) 2001-10-29

Similar Documents

Publication Publication Date Title
IL142216A0 (en) A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
NO975490L (no) Heliobacter pylori antigener og vaksinesammensetninger
NO20003303L (no) Vaksine
DE69717853D1 (de) Verpacktes lichthärtbares gemisch
FR2746302B1 (fr) Compositions cosmetiques comprenant des nanopigments
NO20001914L (no) <alfa>-akryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
NO995891L (no) LH-RH peptidanaloger, anvendelser og farmasoeytiske blandinger inneholdende disse
ID17860A (id) Komposisi vaksin
EP0998942A4 (en) METHOD FOR STABILIZING PEPTIDES AND FREEZERED MEDICINAL COMPOSITIONS THEREOF
DE69726068D1 (de) Härtbare Polymethylsilsesquioxanzusammensetzung
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
PT925273E (pt) Composicoes farmaceuticas contendo acidos 4-oxobutanoicos
BR9707657A (pt) Benzotiofenos formulações contendo os mesmos e métodos
BR9708248A (pt) Benzotiofenos formulações contendo os mesmos e metódos
NO995039D0 (no) Gastrisk bibeholdt farmasöytisk preparat
AU1698699A (en) (helicobacter pylori) vaccine formulations
DE69804573D1 (de) Organopolysiloxan-Zusammensetzungen
EE9900566A (xx) Helicobacter pylori FlgE pol�peptiidi sisaldavad vaktsiinikoostised
EE03511B1 (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
DK1222921T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid
DE69830156D1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
NO981407D0 (no) Protein fra Helicobacter pylori
AU8048698A (en) Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide
AU7945798A (en) Vaccine compositions comprising the (helicobacter pylori) 26kda polypeptide